Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-08-16
2011-08-16
Stockton, Laura L. (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S394000
Reexamination Certificate
active
07999117
ABSTRACT:
The present invention relates to 1H-benzimidazole-4-carboxamides of formula (I),their preparation, and their use as inhibitors of the enzyme poly(ADP-ribose)polymerase for the preparation of drugs.
REFERENCES:
patent: 3864385 (1975-02-01), Feit et al.
patent: 4093726 (1978-06-01), Winn et al.
patent: 6372736 (2002-04-01), Kemp et al.
patent: 6448271 (2002-09-01), Lubisch et al.
patent: 6509365 (2003-01-01), Lubisch et al.
patent: 6696437 (2004-02-01), Lubisch et al.
patent: 6737421 (2004-05-01), Lubish et al.
patent: 7166292 (2007-01-01), Isele et al.
patent: RE39608 (2007-05-01), Lubisch et al.
patent: 7462724 (2008-12-01), Penning et al.
patent: 7550603 (2009-06-01), Zhu et al.
patent: 2003/0100582 (2003-05-01), Sircar et al.
patent: 2006/0229351 (2006-10-01), Zhu et al.
patent: 2007/0179136 (2007-08-01), Penning et al.
patent: 2007/0259937 (2007-11-01), Giranda et al.
patent: 2007/0265324 (2007-11-01), Wernet et al.
patent: 2008/0146638 (2008-06-01), Giranda et al.
patent: 2008/0280867 (2008-11-01), Giranda et al.
patent: 2008/0293795 (2008-11-01), Donawho et al.
patent: 2009/0029966 (2009-01-01), Donawho et al.
patent: 2009/0030016 (2009-01-01), Gandhi et al.
patent: 3522230 (1987-01-01), None
patent: 3830060 (1990-03-01), None
patent: 19916460 (2000-10-01), None
patent: 10021468 (2001-11-01), None
patent: 1354554 (1974-05-01), None
patent: WO-9704771 (1997-02-01), None
patent: WO-9748697 (1997-12-01), None
patent: WO-9806703 (1998-02-01), None
patent: WO-9833802 (1998-08-01), None
patent: WO-9839343 (1998-09-01), None
patent: WO-0026192 (2000-05-01), None
patent: WO-0029384 (2000-05-01), None
patent: WO-0032579 (2000-06-01), None
patent: WO-0121615 (2001-03-01), None
patent: WO-0121634 (2001-03-01), None
patent: WO-0182877 (2001-11-01), None
patent: WO-02068407 (2002-09-01), None
patent: WO-03002698 (2003-01-01), None
patent: WO-03020698 (2003-03-01), None
patent: WO-03094861 (2003-11-01), None
patent: WO-03106430 (2003-12-01), None
patent: WO-2004054515 (2004-07-01), None
patent: WO-2004065370 (2004-08-01), None
patent: WO-2004096793 (2004-11-01), None
patent: WO-2004098494 (2004-11-01), None
patent: WO-2007041357 (2007-04-01), None
patent: WO-2007059230 (2007-05-01), None
Alexy, et al., “Inhibition of ADP-Evoked Platelet Aggregation by Selected Poly(ADP-Ribose) Polymerase Inhibitors,” J Cardiovasc Pharmacol, 2004, 43, pp. 423-431.
Burkart, et al., “Mice lacking the poly (ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin,” Nature Medicine, 1999, 5—Issue 3, pp. 314-319.
Chen, et al., “Potentiation of the antitumor activity of cisplatin in mice by 3-am inobenzamide and nicotinamide,” Cancer Chemotherapy and Pharmacology, 1998, 22, pp. 303-307.
Cuzzocrea, S., et al., “Protective effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthase in a carrageenan-induced model of local inflammation,” European Journal of Pharmacology, 1998, 342, pp. 67-76.
Denny, et al., “Potential Antitumor Agents. 59. Structure-Activity Relationships for 2-Phenylbenzimidazole-4-carboxamides, a New Class of Minimal DNA-Intercalating Agents Which May Not Act via Topoisomerase II,” J Med Chem, 1990, 33 Issue 2, pp. 814-819.
Ehrlich, W., et al., “Inhibition of the induction of collagenase by interleukin-1β in cultured rabbit synovial fibroblasts after treatment with the poly(ADP-ribose)-polymerase inhibitor 3-aminobenzamide,” Rheumatol Int, 1995, 15, pp. 171-172.
Gilchrist et al., “Cyclisation of Ortho-Substituted N-Arylbenzimidoyl Nitrenes. Part 2.1 Preferential Cyclizations at an Ortho-Position Bearing a Methoxycarbonyl Group” J of the Chem Soci Perkin, 1979, pp. 2303-2307.
Griffin, et al., “Novel Benzimidazole and Quinazolinone Inhibitors of the DNA Repair Enzyme Poly (ADP-ribose) polymerase,” Pharmaceutical Sciences, 1996, 2 Issue 1 , pp. 43-47.
International Search Report for application No. PCT/US07/67991, Mailed on Sep. 10, 2008, 3 pages.
IUPAC Commission on Nomenclature of Organic Chemistry: Rules for the Nomenclature of Organic Chemistry, Section E: Stereochemistry (Recommendations 1974), Pure Appl Chem, 1976, 45, 13-30.
Kroger, H., et al., “Synergistic effects of thalidomide and poly(ADP-rose) polymerase inhibition on type Ii collagen-induced arthristis in mice,” Inflammation, 1996, 20—Issue 2, pp. 203-215.
Ohkura, et al., “Mechanism of the Color Reaction between m-Dinitrobenzene and Alkali Cyanide. II. Color Reaction Products of 2,4-Dinitroaniline with Postassium Cyanide (Organic Analysis. LXX II I),” Chem Pharm Bull, 1970, 18—Issue 11, pp. 2164-2168.
Poste et al., “Lipid Vesicles as Carriers for Introducing Biologically Active Materials into Cells,” Methods in Cell Biology, 1976, 33-71, Chapter 4, vol. 14, Academic Press.
Prescott, et al., “Lipid Vesicles as Carriers for Introducing Biologically Active Materials into Cells,” Methods in Cell Biology, 1976, 33-71, vol. 14, Academic Press.
Search Report No. 20030374, Jun. 13, 2003.
Search Report No. 20030487, Sep. 19, 2003.
Search Report No. 20050150, Apr. 22, 2005.
Search Report No. 20050207, May 27, 2005.
Supplementary European search report for publication No. EP2012780A2, mailed on May 11, 2009, 2 pages.
Szabo, C., et al., “Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase,” Proc Natl Acad Sci USA, 1998, 95, pp. 3867-3872.
Thiemermann, C., et al., “Inhibition of the activity of poly (ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle,” Proc. Natal. Acad. Sci. USA, 1997, 94, pp. 679-683.
U.S. Appl. No. 09/830,992, filed May 3, 2001, inventor Wilfried Lubisch.
U.S. Appl. No. 10/935,683, filed Sep. 7, 2004, inventor Wilfried Lubisch.
U.S. Appl. No. 11/401,635, filed Apr. 11, 2006, inventor Gui-Dong Zhu.
U.S. Appl. No. 11/536,994, filed Sep. 29, 2006, inventor Thomas D. Penning.
U.S. Appl. No. 11/623,996, filed Jan. 17, 2007, inventor Wolfgang Wernet.
U.S. Appl. No. 11/743,200, filed May 2, 2007, inventor Vincent L. Giranda.
U.S. Appl. No. 11/970,828, filed Jan. 8, 2008, inventor Vincent L. Giranda.
U.S. Appl. No. 12/058,478, filed Mar. 28, 2008, inventor Vincent L. Giranda.
U.S. Appl. No. 12/116,823, filed May 7, 2008, inventor Cherrie K. Donawho.
U.S. Appl. No. 12/117,452, filed May 8, 2008, inventor Cherrie K. Donawho.
U.S. Appl. No. 12/173,213, filed Jul. 15, 2008, inventor Virajkumar B. Gandhi.
Weltin, et al., “Immunosuppressive activities of 6(5h)-phenanthridinone, a new poly (adp-ribose) polymerase inhibitor,” Int J Immunopharmac. , 1995, 17—Issue4, pp. 265-271.
White A.W. et al., “Potentiation of cytotoxic drug activity in human cell lines, by amine substituted 2-arylbenzimidazole-4-carboxamide PARP-1 inhibitors,” Bioorganic and medicinal chemistry letters, 2004, 14 (10), pp. 2433-2437.
Gandhi Virajkumar B.
Giranda Vincent L.
Gong Jianchun
Penning Thomas D.
Thomas Sheela A.
Corbin Johanna M.
Steele Gregory L.
Steele Susan L.
Stockton Laura L.
LandOfFree
Substituted 1H-benzimidazole-4-carboxamides are potent PARP... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 1H-benzimidazole-4-carboxamides are potent PARP..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 1H-benzimidazole-4-carboxamides are potent PARP... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2691211